POAI

Predictive Oncology Inc
0.6249
0.0499 (8.68%)
Upgrade to Real-Time
Regular Market
0.6249
Volume 551,891
Bid Price 0.61
Ask Price 0.625
News -
Day High 0.6364

Low
0.21

52 Week Range

High
1.10

Day Low 0.5907
Company Name Stock Ticker Symbol Market Type
Predictive Oncology Inc POAI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0499 8.68% 0.6249 11:44:57
Open Price Low Price High Price Close Price Prev Close
0.6299 0.5907 0.6364 0.575
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
766 551,891 $ 0.6204207 $ 342,405 - 0.21 - 1.10
Last Trade Time Type Quantity Stock Price Currency
11:44:57 500 $ 0.6249 USD

Period:

Draw Mode:

Predictive Oncology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.64M 15.42M 77.70M $ 1.42M $ - -0.37 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 903.51k 8.80%

more financials information »

Predictive Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical POAI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.500.6480.46390.545719917,5030.124924.98%
1 Month0.370.6480.35020.4862507536,5680.254968.89%
3 Months0.2650.6480.2510.4459815373,7030.3599135.81%
6 Months0.44490.6480.210.3944556315,8180.1840.46%
1 Year0.851.100.210.4618469510,363-0.2251-26.48%
3 Years3.584.420.211.191,379,477-2.96-82.54%
5 Years0.5815.390.211.201,150,2040.04397.56%

Predictive Oncology Description

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.